Constipation is a very common gastrointestinal problem, with causes including insufficient dietary fiber intake, low daily physical activity, and decreased intestinal peristalsis due to advancing age. There are a wide variety of laxative products on the market, among which pharmaceutical-grade magnesium oxide is an osmotic laxative raw material that improves constipation through a mild physical mechanism with relatively low irritation.
After oral administration of pharmaceutical-grade magnesium oxide, a portion of the powder reacts in the stomach to form magnesium chloride, which is absorbed by the human intestinal tract. Meanwhile, the unabsorbed magnesium oxide reaches the large intestine, where it increases the internal osmotic pressure of the intestinal tract. Once the osmotic pressure rises, a portion of the water from body tissues enters the intestinal lumen, and the feces are gradually softened after being fully permeated by water. At the same time, the volume of fluid in the intestines increases, which mildly stimulates the peristalsis of the intestinal smooth muscle to propel feces out of the body.
Unlike stimulating laxatives, magnesium oxide laxation does not rely on directly stimulating the enteric nervous system to take effect. It causes less irritation to the intestinal mucosa and is less likely to produce strong abdominal pain reactions with short-term use, making it suitable for short-term improvement of chronic constipation in elderly groups or individuals with weaker constitutions. However, the laxative effect of magnesium oxide is dose-dependent: small doses tend toward antacid and stomach-protecting functions, while the laxative effect appears only after increasing the dosage.
Even though its nature is mild, magnesium oxide laxative preparations are not suitable for continuous, uninterrupted long-term use. Relying on external osmotic pressure to stimulate defecation over a long period may affect the intestines’ own peristaltic regulation ability to a certain extent, and constipation symptoms may recur after discontinuing the medication. Managing constipation should prioritize lifestyle adjustments, such as increasing the intake of vegetables and whole grains, ensuring a daily water intake, and engaging in moderate exercise, thereby improving intestinal defecation status from the root. Medicinal laxation can serve as a phased auxiliary means.
Regarding contraindications, individuals who have already experienced abdominal pain, intestinal obstruction, or unexplained gastrointestinal bleeding are not suitable for using magnesium oxide laxative preparations. People with impaired renal function should use it with caution to prevent the accumulation of magnesium ions. When using laxative products containing magnesium oxide, individuals should carefully read the drug instructions and control the single dose. If constipation still does not improve for a long time after adjusting lifestyle habits, it is recommended to visit a hospital for medical evaluation to rule out the underlying causes of constipation.